Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia.

Gleason PP, Kapoor WN, Stone RA, Lave JR, Obrosky DS, Schulz R, Singer DE, Coley CM, Marrie TJ, Fine MJ.

JAMA. 1997 Jul 2;278(1):32-9.

PMID:
9207335
2.
3.

Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.

Feldman RB, Rhew DC, Wong JY, Charles RA, Goetz MB; American Thoracic Society..

Arch Intern Med. 2003 Jul 28;163(14):1718-26.

PMID:
12885688
5.

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.

Frei CR, Jaso TC, Mortensen EM, Restrepo MI, Raut MK, Oramasionwu CU, Ruiz AD, Makos BR, Ruiz JL, Attridge RT, Mody SH, Fisher A, Schein JR.

Curr Med Res Opin. 2009 Apr;25(4):859-68. doi: 10.1185/03007990902779749 .

PMID:
19231913
6.

Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.

Mahboub B, Al Zaabi A, Al Ali OM, Ahmed R, Niederman MS, El-Bishbishi R.

BMC Pulm Med. 2015 Sep 30;15:112. doi: 10.1186/s12890-015-0108-x.

7.

Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia.

Gilbert K, Gleason PP, Singer DE, Marrie TJ, Coley CM, Obrosky DS, Lave JR, Kapoor WN, Fine MJ.

Am J Med. 1998 Jan;104(1):17-27.

PMID:
9528715
8.

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.

Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.

Clin Ther. 2008 Feb;30(2):358-71. doi: 10.1016/j.clinthera.2008.01.023.

PMID:
18343274
9.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
10.

Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia.

Malone DC, Shaban HM.

Ann Pharmacother. 2001 Oct;35(10):1180-5.

PMID:
11675841
11.

[Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].

Díaz A, Kuzmanic G, Platzer L, Sanfuentes F, Espinoza MA, Saldías F.

Rev Med Chil. 2003 Aug;131(8):847-56. Spanish.

PMID:
14558238
12.

Influence of deviation from guidelines on the outcome of community-acquired pneumonia.

Menéndez R, Ferrando D, Vallés JM, Vallterra J.

Chest. 2002 Aug;122(2):612-7.

PMID:
12171840
13.

Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.

Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menéndez R, Lopardo G, Torres A, Rossi P, Ramirez JA; Community-Acquired Pneumonia Organization (CAPO) Investigators..

Arch Intern Med. 2009 Sep 14;169(16):1515-24. doi: 10.1001/archinternmed.2009.265.

PMID:
19752410
14.

Community-acquired pneumonia in the elderly.

Fung HB, Monteagudo-Chu MO.

Am J Geriatr Pharmacother. 2010 Feb;8(1):47-62. doi: 10.1016/j.amjopharm.2010.01.003. Review.

PMID:
20226392
15.

Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.

Venditti M, Falcone M, Corrao S, Licata G, Serra P; Study Group of the Italian Society of Internal Medicine..

Ann Intern Med. 2009 Jan 6;150(1):19-26.

PMID:
19124816
16.
17.
18.

Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia.

Dean NC, Silver MP, Bateman KA, James B, Hadlock CJ, Hale D.

Am J Med. 2001 Apr 15;110(6):451-7.

PMID:
11331056
19.

Use of guidelines in treating community-acquired pneumonia.

Marras TK, Chan CK.

Chest. 1998 Jun;113(6):1689-94.

PMID:
9631814
20.

Supplemental Content

Support Center